Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today is much better for us; and you too?
News: $AMRS Amyris to Present April 15 at Paradigm Capital Biosynthesis Conference - Exploring the Most Disruptive Technology in the Cannabis Industry
EMERYVILLE, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at th...
Read the whole news https://marketwirenews.com/news-releases/amyris-to-present-april-15-at-paradigm-capital-biosynthesis-conference-exploring-the-most-disruptive-technology-in-the-cannabis-industry-7899086.html
$AMRS played some real dirty pool with the way they threw out certain news articles. They ought to be sued over it. Shady shady. However....I expect the GOOD NEWS will start now at some point....
glad I was migrating to ATRS since last fall. Still stings a tad but oh well. Who the hell knows with this pos now... cry wolf too many times and some day someone will call the bluff.
SMH
Glad I only put $5k in this...but I think we will rise up again. They have lots more in the tank.
Melo reminds me of eves lol
* * $AMRS Video Chart 03-22-2019 * *
Link to Video - click here to watch the technical chart video
He brings them short sellers for sure
Go home clay nobody likes you. Look at the discussion here it’s crickets. You scared everyone away lol. There is barn Fire and you are go to going to about stupid stairs. Use those stairs to get out of here
* * $AMRS Video Chart 03-21-2019 * *
Link to Video - click here to watch the technical chart video
$AMRS Amyris 4Q Loss/Shr $1.03 >AMRS
* * $AMRS Video Chart 02-15-2019 * *
Link to Video - click here to watch the technical chart video
LoL ?? riiight, long here
blah blah blah go away
* * $AMRS Video Chart 02-12-2019 * *
Link to Video - click here to watch the technical chart video
Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications
Amyris, Inc. (Nasdaq:AMRS), and IDRI (Infectious Disease Research Institute), are pleased to announce IDRI’s receipt of a $4.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases (part of the U.S. National Institutes of Health) to discover sustainable alternatives to shark squalene to use as vaccine adjuvants (grant number: R01AI135673). Funding is provided by a special bioengineering research grant aimed at bringing engineering expertise to focus on a biomedical problem and ultimately develop a new solution.
Adjuvants are added to vaccines to enhance their effectiveness; the aim of the new project is to discover and evaluate novel, sustainable squalene-like compounds produced by bio- or chemical engineering for vaccine adjuvant applications.
IDRI has selected Amyris and the University of Nottingham, (UK) as partners because of their record of success in engineering pure molecules from sustainable sources at low cost. Instead of sourcing squalene from sharks, Amyris uses patented biotechnology to create squalene-like compounds using sugarcane syrup as the fermentation feedstock. Amyris has developed specific expertise as a clean manufacturer of sustainably sourced squalane.
“While one of our goals is to find a replacement for the pharmaceutical squalene derived from sharks, another key driver of this project is to understand how squalene formulations actually work as adjuvants,” said Christopher Fox, PhD, Vice President of Formulations at IDRI and principal investigator for the project. “By generating compounds with various structural alterations, we can study the structure-function relationship of squalene-like molecules and shine a light on their mechanisms of action.”
Fox added that key attributes of adjuvants in vaccines are the ability to improve an immune response and minimize the dose of vaccine necessary to confer immunity, which is particularly important where there is a disease outbreak that results in a vaccine shortage. “Development of this technology could enable formulations that effectively increase the number of vaccine doses available in the event of an influenza pandemic for example,” Fox said.
“We’re pleased to assist IDRI and to work with the University of Nottingham in this endeavor,” Amyris President, Research & Development Joel Cherry, Ph.D. said. “Today, we’re producing enormous amounts of squalane for customers around the world. This is a sustainably sourced version of squalane, with high purity and performance, and we’re looking forward to lending our assistance to apply what we know to benefit more people.”
* * $AMRS Video Chart 02-11-2019 * *
Link to Video - click here to watch the technical chart video
Amyris Appoints Industry Veteran as President, Sweeteners and Ingredients, to Deliver Accelerated Growth
EMERYVILLE, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment of Oreste Fieschi as President of Sweeteners & Ingredients, to lead the commercial growth of its sweetener business and the implementation of its strategy to build capability across the entire ingredients portfolio.
Oreste has a successful track record in commercial leadership roles in the food and beverage and natural ingredients sectors, along with deep expertise in global markets. This new position is driven by growth across Amyris's businesses and within the expanding market for the company's new, sugarcane-derived zero calorie sweetener.
Most recently, he led global sales and marketing as the Chief Commercial Officer for Naturex, a leader in natural ingredients recently bought by Givaudan. He has over 20 years' experience in senior commercial roles in diverse markets including chemicals, personal care, and food & beverage, including six years leading the sales growth strategy for Tate & Lyle Latin America. Prior to that, he held key commercial and business development roles with such companies as IFF, a leading developer and manufacturer of flavors and fragrances. Oreste holds a Master's degree in Business Administration from the Business School São Paulo, BSP (in partnership with Toronto University), and several other education certifications in finance and accounting, marketing, and chemical engineering.
"We welcome Oreste to Amyris at an inflection point when our businesses are experiencing solid, recurring revenue growth," said John Melo, Amyris President & CEO. "His proven experience as a successful leader in the markets we are growing, gives us a significant advantage toward maximizing the real opportunities ahead of us for revenue growth through key partnerships for our No Compromise(TM) ingredients."
Based in São Paulo and fluent in English, Portuguese and Spanish, Oreste will leverage his deep expertise globally to execute on Amyris's accelerated demand for the sweetener business.
Not being an Internet tough guy. You come around on big volume and your videos are basic.
Technical view. Green to red move at 5.45. Possible First red day. Good sign of weakness this should drop more if it closes below 5.45. maybe another red day tomorrow for a good dip buy. Also the 255M deal isn't officially done yet.
Good. Thanks for reply. We picked up another 1k this morning—$5.08.
I only blocked him for myself.
Put him on ignore for yourself. I hope you did not ban Clay from this message board itself. We have some 1000s of AMRS shares, and find his charts useful, but not controlling how we invest in AMRS. TIA
Agreed - waiting for the confirmation on reversal :)
This will be pushing $7 in the next couple days
I blocked that idiot.
Right. He wasn’t conjured, he’s like a bad penny.
He was going to appear regardless, always does with big movement
you talked him up....
lol
* * $AMRS Video Chart 02-05-2019 * *
Link to Video - click here to watch the technical chart video
Skyrocketing after hours, tomorrow up we go ! $$$$$$$ love it
Welcome aboard bro! Hell Yeah!
I think it should run till Thursday $$$$$$$$$ people are waking up on this one
Volume speaks for itself. Gap up tomorrow.
Agreed! It should gap up at opening tomorrow, and hopefully we will find another winner as well !
When more catch on, they will come. We got in this AM and i was thinking more would be here by now. Hey, not gonna lie, it's nice not to have to deal with shorties or negative posts all day.
It seems that is only you and me in this room ! Hahaha don’t see anybody else
Great day bro! $$$$$ so glad I got in this morning
I'm with you. Keeping a close eye, but going to hold. Crazy fun to watch
Almost at 7$, holding till tomorrow! The volume is getting wild $$$$$$
I'm curious what type of movement they're seeing on their artificial sweetener, and what type of customer feedback they're getting.
These are both potentially very big products, and if sales materialize, then in combination with cosmetics, they could just scrap the rest of their products.
We are heading to 8-9$ in the next 10 days, no doubt! Wait to see the board later, this one should be in the first top 5 stocks in iHub today !
Run baby run $$$$
You may be right about that 6 dollars. Can't wait until we find out more. CBD will send this back to it's 6 month HOD over 9
Followers
|
108
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4221
|
Created
|
03/08/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |